Hans Demmelmair

Dr. Hans Demmelmair

Ludwig-Maximilians-Universität, Division of Metabolic and Nutritional Medicine, Dr. von Hauner Children’s Hospital, University of Munich Medical Center, 80337 Munich, Germany
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Best Practice & Research Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
HDHans Demmelmair
Hans Demmelmair
BKBerthold Koletzko
Berthold Koletzko

28 July 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
HDHans Demmelmair
Hans Demmelmair
CPChristine Prell
Christine Prell
NTNiklas Timby
Niklas Timby
BLBo Lars Lonnerdal
Bo Lars Lonnerdal
The provision of essential and non-essential amino acids for breast-fed infants is the major function of milk proteins. In addition, breast-fed infants might benefit from bioactivities of milk proteins, which are exhibited in the intestine during the digestive phase and by absorption of intact proteins or derived peptides. For lactoferrin, osteopontin and milk fat globule membrane proteins/lipids, which have not until recently been included in substantial amounts in infant formulas, in vitro experiments and animal models provide a convincing base of evidence for bioactivities, which contribute to the protection of the infant from pathogens, improve nutrient absorption, support the development of the immune system and provide components for optimal neurodevelopment. Technologies have become available to obtain these compounds from cow´s milk and the bovine compounds also exhibit bioactivities in humans. Randomized clinical trials with experimental infant formulas incorporating lactoferrin, osteopontin, or milk fat globule membranes have already provided some evidence for clinical benefits. This review aims to compare findings from laboratory and animal experiments with outcomes of clinical studies. There is good justification from basic science and there are promising results from clinical studies for beneficial effects of lactoferrin, osteopontin and the milk fat globule membrane complex of proteins and lipids. Further studies should ideally be adequately powered to investigate effects on clinically relevant endpoints in healthy term infants.

1 March 2017 in Clinics in Perinatology
Verified
Journal Article
Open access
HDHans Demmelmair
Hans Demmelmair
BKBerthold Koletzko
Berthold Koletzko
Animal studies show that the lactation period contributes to metabolic programming of the offspring and that oral leptin and insulin show bioactivity. Stage of lactation, duration of gestation, maternal body composition, and maternal diet seem to influence the concentrations of small molecules in human milk. Variability of small molecule concentrations seems higher in preterm milk than in term milk. Insulin in human milk shows concentrations similar to plasma. Leptin concentration is lower in milk than in plasma and reflects maternal body mass index. Early in lactation, leptin could contribute to mediating the association between maternal and infant body composition.

31 August 2008 in Clinical Nutrition
Verified
Journal Article
Closed access
DDDavid F. Driscoll
David F. Driscoll
BBBruce R. Bistrian
Bruce R. Bistrian
HDHans Demmelmair
Hans Demmelmair
BKBerthold Koletzko
Berthold Koletzko

1 April 2020 in Clinical Nutrition
Verified
Journal Article
Closed access
AGAntonio Gázquez
Antonio Gázquez
MPMaria Teresa Prieto-Sanchez
Maria Teresa Prieto-Sanchez
JBJ.E. Blanco-Carnero
J.E. Blanco-Carnero
MRM. Ruíz-Palacios
M. Ruíz-Palacios
ANAnibal Nieto
Anibal Nieto
ELElvira Larque
Elvira Larque

1 December 2019 in Clinical Nutrition
Verified
Journal Article
Closed access
HDHans Demmelmair
Hans Demmelmair
JØJannike Øyen
Jannike Øyen
TPTina Pickert
Tina Pickert
ARAstrid Rauh-Pfeiffer
Astrid Rauh-Pfeiffer
KSKjell Morten Stormark
Kjell Morten Stormark
BKBerthold Koletzko
Berthold Koletzko